Cellular and tissue-based products (CTPs) — sometimes called skin substitutes, biologic dressings, or amniotic allografts — are advanced therapies for chronic wounds that have failed standard care. Coverage of these biologics is among the most documentation-intensive areas of wound care reimbursement. Healix360 supports access to advanced mobile wound care by coordinating prior authorizations, assembling the documentation required by the Local Coverage Determination, and ensuring the right product reaches the right patient on the right schedule. Care is coordinated and provided directly by licensed physicians and nurse practitioners.
Call 877-545-1300 or request a provider to begin care. Healix360 serves Southern California and Nevada and accepts Medicare Part B and most major insurance plans.